A number of key changes to the UK's regulation of the sale of medical devices took effect upon the UK's exit from the EU. These changes have been on the horizon since the arrival of the new EU medical device regulations a number of years ago, and will continue to reshape the regulatory landscape for these products over the next few years.
Legal Insights & Industry Updates
Life, business and the law
The law never stands still, and the way it applies to you and your organisation is constantly evolving. Our people are on top of these developments and can keep you up to date with some of the most interesting aspects of these changes. Check out our articles and updates for our perspective on issues that might affect you.
Latest articles from Jamie Watt
The European landscape for the protection of brand rights changed significantly on the UK's exit from the EU. Brand rights holders are recommended to be cognisant of the changes, and ensure that their European brand protection strategies remain fit for purpose.
One of the consequences of the UK choosing to take a path apart from that chosen by the EU is the development by the UK of an investment control regime. This has recently materialised into a more thought out form, via the publication by the UK government of the UK's proposed National Security and Investment Bill.
What will the end of Brexit mean in practice for UK businesses trading internationally in the EU and beyond?
On 31 December 2020 the transition period relating to the UK's exit from the European Union will end. There is no trade deal yet in place between the UK and the EU, though some trade arrangements are in place, for example with Japan. There is uncertainty. But it remains possible for businesses to mitigate risk by undertaking some forward planning and by considering what they may need to do and making preparations.
Scotland is set to have its first ever Biometrics Commissioner, as a direct response to the recognition from government that biometric data can be collected by the police often without individual consent, and needs particular regulatory attention.